Drug-Eluting Stents Could Experience Blockage From New Safety Data

Public questions concerning the safety of the Taxus andCypher drug-eluting stents increased measurably last week amid results reported at a major cardiology conference and a disclosure by Boston Scientific that Taxus is associated with an increased risk of blood clots